The Trust Board is the governing body of Great Ormond Street Hospital (GOSH).
The Trust Board is responsible for the directing and controlling the affairs of GOSH. It also provides a framework of governance to enable GOSH to deliver quality healthcare and health improvement. It comprises six Non-Executive Directors, a Chairman and six Executive Directors (senior staff of the hospital), including the Chief Executive.
Collectively they take corporate responsibility for the strategic development and actions of GOSH.
The Trust Board meets eight times a year – six times for formal meetings and twice for strategic meetings to review past performance and discuss future plans.
Members of the Trust Board
Sir Michael Rake, Chairman
Sir Michael Rake was appointed as Chairman at a meeting of the Members’ Council in May 2017 and took up his post in November 2017. Sir Michael Rake’s former principal roles include Chairman (both UK and International) of KPMG, Chairman of easyJet, President of the Confederation of British Industry, Deputy Chairman of Barclays and director of the Financial Reporting Council.
Dr Peter Steer, Chief Executive
Dr Peter Steer is the Chief Executive of the Trust and is accountable to the Chair of the Foundation Trust, its Board of Directors and the Members Council. He has responsibility for the strategic and operational delivery of the Trust’s business plans, supported by his executive team.
Peter attends the three Board Assurance Committees: Audit Committee, Quality and Safety Assurance Committee and Finance and Investment Committee.
Akhter Mateen, Deputy Chairman
Mr Akhter Mateen has an MBA in Finance and holds a non-executive director position at a multi-national company and is also a director of a not-for-profit foundation.
Akhter is Chair of the Audit Committee and a member of the Finance and Investment Committee.
James Hatchley, Senior Independent Director
Mr. James Hatchley has over 25 years of executive-level experience working in the financial services industry. He is currently Group Strategy Director for 3i Group plc and prior to that was European Chief Operating Officer of Kohlberg Kravis and Roberts, a US-listed global investment firm.
James is a member of the Audit Committee, Quality and Safety Assurance Committee and the Finance and Investment Committee.
Professor Rosalind Smyth, Non-Executive Director and Director, UCL Great Ormond Street Institute of Child Health
Professor Rosalind Smyth is Director of the UCL Great Ormond Street Institute of Child Health. She is Professor of Child Health at the Institute, as well as an honorary consultant in Paediatric Respiratory Medicine at GOSH. Rosalind is a member of the Quality and Safety Assurance Committee.
Lady Amanda Ellingworth, Non-Executive Director
Amanda was a senior social worker focusing on children and families before moving into Board level roles, including 12 years on the Board of a small Foundation Trust and Chair of a large housing association. Currently, Amanda is Chair of Plan International UK, Lay Advisor of the Royal College of Emergency Medicine and Deputy Chair of Barnado’s, the major children’s charity.
Amanda is a member of the Quality and Safety Assurance Committee.
Professor Stephen Smith, Non-Executive Director
Professor Stephen Smith was Dean of Medicine at Imperial College and Chief Executive of Imperial College Healthcare NHS Trust from 2007-2011. Most recently he was Dean of the Faculty of Medicine At the University of Melbourne and Chair of the Melbourne Academic Centre for Health until October 2015.
Stephen chairs the Quality and Safety Assurance Committee.
Chris Kennedy, Non-Executive Director
Chris Kennedy is a qualified accountant and is currently chief financial officer of Micro Focus one of the largest pure-play software companies in the world.
Prior to this Chris was CFO of ARM Holdings plc, the UK’s largest listed technology company. He has spent the last 20 years in senior global, financial and commercial roles in a variety of sectors including 5 years at EasyJet.
Chris spent 17 years at EMI as COO of EMI International running both the commercial and finance functions together with the growing digital music business, and later became CFO of the Group. Chris holds a degree in electrical sciences from Cambridge University.
Nicola Grinstead, Deputy Chief Executive
Nicola is responsible for the day to day operational running of the hospital. This includes two clinical divisions, International and Private Patients, Estates and Facilities, Risk and Clinical Governance, and Quality Improvement. She attends the three Board sub-committees: Audit, Finance and Investment, and Quality and Safety Assurance.
Matthew Shaw, Medical Director
Matthew is the Trust’s lead for patient and staff safety and clinical quality. He provides professional leadership to the medical body and is also responsible for postgraduate medical education and training for doctors, medical workforce development and partnership services.
Matthew attends the Quality and Safety Assurance Committee.
Alison Robertson, Chief Nurse
Alison leads on the professional standards and development of nursing and all other non-medical clinical staff groups. She is also responsible for patient and public involvement and engagement in the Trust.
Alison is involved in ensuring that all professional standards for nurses and allied health professionals (AHPs) are adhered to and they work to improve the care of children, young people and their families. In partnership with other colleagues, Alison is responsible for delivering the quality agenda with a specific focus on the patient experience.
Alison attends the Quality and Safety Assurance Committee.
Helen Jameson, Interim Chief Finance Officer
Helen is responsible for the financial management of the Trust, as well as leading on contracting and information technology. Helen attends the Audit Committee and the Finance Investment Committee.
Ali Mohammed, Director of Human Resources and Organisational Development
Ali leads the development and delivery of the Trust’s human resources and organisational development policy, strategy and improvement programmes.
He attends the Quality and Safety Assurance Committee and the Board of Directors’ Remuneration Committee and Nominations Committee.
Matthew Tulley, Director of Development
Matthew leads the work to redevelop the Trust’s buildings, ensuring they are suitable to support the capacity and quality ambitions of our clinical strategy.
Matthew describes the redevelopment programme as highly complex and challenging, but at the same time exciting and rewarding: “I’ve been at GOSH just over two years and the time has flown by. You quickly understand what a special place this is. Working with clinical teams to deliver our future hospital facilities is a real privilege, as is seeing the difference it makes to our patients, their families and carers.”
Professor David Goldblatt, Director of Research and Development
Professor David Goldblatt is a Consultant Paediatric Immunologist at GOSH and Professor of Vaccinology and Immunology and Head of the Immunobiology Unit at the UCL GOS Institute of Child Health.
He is also the Director of Clinical Research and Development at GOSH and the Director of the National Institute for Health Research (NIHR) Biomedical Research Centre at GOSH/UCL. David leads the strategic development of clinical research and development across the Trust.
Cymbeline Moore, Director of Communications
Cymbeline is a trained journalist that has worked in communications for the NHS for the last seven years.
After working for the Trinity Mirror group of newspapers as a news editor she moved into NHS communications at Hammersmith Hospitals. During her time there she became head of public relations and then director of communications for the newly formed Imperial College Healthcare NHS Trust.
She has been head of communications for Great Ormond Street Hospital and Charity since September 2012. In this joint role she oversees all hospital and charity press and PR activity and is responsible for family stewardship, celebrity liaison and VIP visits.